Rotarix Approval History
FDA Approved: Yes (First approved April 3, 2008)
Brand name: Rotarix
Generic name: rotavirus vaccine, live attenuated
Dosage form: Oral Suspension
Treatment for: Prevention of Rotavirus Gastroenteritis
Rotarix (rotavirus vaccine live) is an oral, two-dose, live attenuated vaccine for the prevention of rotavirus gastroenteritis in children.
Development History and FDA Approval Process for Rotarix
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.